A detailed history of Jane Street Group, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 19,976 shares of ANIP stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,976
Previous 26,263 23.94%
Holding current value
$1.13 Million
Previous $1.67 Million 28.77%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$54.33 - $65.72 $341,572 - $413,181
-6,287 Reduced 23.94%
19,976 $1.19 Million
Q2 2024

Aug 14, 2024

SELL
$58.53 - $68.82 $2.4 Million - $2.83 Million
-41,090 Reduced 61.01%
26,263 $1.67 Million
Q1 2024

May 15, 2024

BUY
$54.2 - $69.69 $2.88 Million - $3.7 Million
53,136 Added 373.75%
67,353 $4.66 Million
Q4 2023

Feb 14, 2024

SELL
$48.72 - $65.43 $320,139 - $429,940
-6,571 Reduced 31.61%
14,217 $783,000
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $1.05 Million - $1.34 Million
20,788 New
20,788 $1.21 Million
Q1 2023

May 15, 2023

SELL
$37.61 - $45.72 $550,121 - $668,746
-14,627 Reduced 55.31%
11,820 $469,000
Q4 2022

Feb 14, 2023

BUY
$31.9 - $41.95 $843,659 - $1.11 Million
26,447 New
26,447 $1.06 Million
Q1 2022

May 17, 2022

SELL
$26.91 - $47.15 $253,330 - $443,870
-9,414 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$32.97 - $56.85 $310,379 - $535,185
9,414 New
9,414 $434,000
Q1 2021

May 18, 2021

SELL
$28.4 - $36.14 $399,502 - $508,381
-14,067 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$23.69 - $31.47 $333,247 - $442,688
14,067 New
14,067 $409,000
Q1 2018

May 15, 2018

SELL
$56.98 - $72.41 $363,646 - $462,120
-6,382 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$53.3 - $74.56 $340,160 - $475,841
6,382
6,382 $411,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.